Immunogenicity and safety of the 2015 Southern Hemisphere formulation of a split-virion inactivated quadrivalent vaccine

An inactivated split-virion quadrivalent influenza vaccine (IIV4; Fluzone® Quadrivalent; Sanofi Pasteur) has been available in the US since 2013 and in the Southern Hemisphere since 2015. Here, we describe the results of an open-label, post-licensure trial (WHO Universal Trial Number, U1111-1143-925...

Descripción completa

Detalles Bibliográficos
Autores principales: Montalban, Cecilia, Montellano, May Book, Santos, Jaime, Lavis, Nathalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861779/
https://www.ncbi.nlm.nih.gov/pubmed/28933626
http://dx.doi.org/10.1080/21645515.2017.1377378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861779/
https://www.ncbi.nlm.nih.gov/pubmed/28933626
http://dx.doi.org/10.1080/21645515.2017.1377378

Ejemplares similares